{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-22T02:06:54.84491+00:00","published_at":"2026-10-21T04:47:21.26074+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1pgb09y1hh1zoy","event_type":"CEO_CHANGED","effective_at":"2025-09-23","detected_at":"2026-10-21T04:47:21.26074+00:00","subject_ids":["alpha:person:eric-a-adams","alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0"],"caused_claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:67b5cdadce1a068f02322c3bf0fbc1dfa22a798b11fa670f243ee1e981ea7b54"],"summary":"Eric A. Adams executive of InMed Pharmaceuticals Inc., effective 2025-09-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1fjgcw3qgxpkn","event_type":"CFO_CHANGED","effective_at":"2025-09-23","detected_at":"2026-10-21T04:47:21.26074+00:00","subject_ids":["alpha:person:netta-jagpal","alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0"],"caused_claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:e0e90afaef68572d3c27f13be57966a41f4970916e9e6cacbc6af1018a380bc2"],"summary":"Netta Jagpal executive of InMed Pharmaceuticals Inc., effective 2025-09-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:18c6i0p1hyjhdb","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-21T04:47:21.26074+00:00","subject_ids":["alpha:person:john-bathery","alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0"],"caused_claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e"],"summary":"John Bathery seat on InMed Pharmaceuticals Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:8b60nok4ss98","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-21T04:47:21.26074+00:00","subject_ids":["alpha:person:neil-klompas","alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0"],"caused_claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e"],"summary":"Neil Klompas seat on InMed Pharmaceuticals Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:qpjuqc80v986","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-21T04:47:21.26074+00:00","subject_ids":["alpha:person:nicole-lemerond","alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0"],"caused_claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e"],"summary":"Nicole Lemerond seat on InMed Pharmaceuticals Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1tx4rww1896ona","event_type":"COMMITTEE_CREATED","effective_at":"2022-01-01","detected_at":"2026-10-21T04:47:21.26074+00:00","subject_ids":["alpha:committee:inmed-pharmaceuticals-inc:audit-compensation-chair-nominating-and-governance","alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0"],"caused_claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e"],"summary":"Audit; Compensation · Chair; Nominating and Governance committee of InMed Pharmaceuticals Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1dhp4hg1164m2g","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2022-01-01","detected_at":"2026-10-21T04:47:21.26074+00:00","subject_ids":["alpha:person:nicole-lemerond","alpha:committee:inmed-pharmaceuticals-inc:audit-compensation-chair-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e"],"summary":"Nicole Lemerond member of Audit; Compensation · Chair; Nominating and Governance, effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:11rmy2vpl1jd9","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-21T04:47:21.26074+00:00","subject_ids":["alpha:person:andrew-hull","alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0"],"caused_claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e"],"summary":"Andrew Hull seat on InMed Pharmaceuticals Inc., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1oh5j901w90xxy","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-21T04:47:21.26074+00:00","subject_ids":["alpha:person:eric-a-adams","alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0"],"caused_claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e"],"summary":"Eric A. Adams seat on InMed Pharmaceuticals Inc., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:l7s7p31ovoc85","event_type":"COMMITTEE_CREATED","effective_at":"2016-01-01","detected_at":"2026-10-21T04:47:21.26074+00:00","subject_ids":["alpha:committee:inmed-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair","alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0"],"caused_claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e"],"summary":"Audit; Compensation; Nominating and Governance · Chair committee of InMed Pharmaceuticals Inc., effective 2016-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1r5qjvj1vbrcjv","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2016-01-01","detected_at":"2026-10-21T04:47:21.26074+00:00","subject_ids":["alpha:person:andrew-hull","alpha:committee:inmed-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e"],"summary":"Andrew Hull member of Audit; Compensation; Nominating and Governance · Chair, effective 2016-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:5","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:andrew-hull","object_label":"Andrew Hull","object_source_name_forms":[],"value":"Andrew Hull: Director, Audit; Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:andrew-hull","name":"Andrew Hull"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"InMed Pharmaceuticals Inc. DEF 14A 2025-11-03","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":"2025-11-03","retrieved_at":"2026-04-28T22:18:02.792+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-11-03","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:6","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:eric-a-adams","object_label":"Eric A. Adams","object_source_name_forms":[],"value":"Eric A. Adams: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:eric-a-adams","name":"Eric A. Adams"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"InMed Pharmaceuticals Inc. DEF 14A 2025-11-03","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":"2025-11-03","retrieved_at":"2026-04-28T22:18:02.792+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-11-03","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:7","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-bathery","object_label":"John Bathery","object_source_name_forms":[],"value":"John Bathery: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-bathery","name":"John Bathery"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"InMed Pharmaceuticals Inc. DEF 14A 2025-11-03","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":"2025-11-03","retrieved_at":"2026-04-28T22:18:02.792+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-11-03","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:8","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:neil-klompas","object_label":"Neil Klompas","object_source_name_forms":[],"value":"Neil Klompas: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:neil-klompas","name":"Neil Klompas"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"InMed Pharmaceuticals Inc. DEF 14A 2025-11-03","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":"2025-11-03","retrieved_at":"2026-04-28T22:18:02.792+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-11-03","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:9","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:nicole-lemerond","object_label":"Nicole Lemerond","object_source_name_forms":[],"value":"Nicole Lemerond: Director, Audit; Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:nicole-lemerond","name":"Nicole Lemerond"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"InMed Pharmaceuticals Inc. DEF 14A 2025-11-03","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":"2025-11-03","retrieved_at":"2026-04-28T22:18:02.792+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-11-03","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:10","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:eric-a-adams","object_label":"Eric A. Adams","object_source_name_forms":[],"value":"Eric A. Adams: President, Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:eric-a-adams","name":"Eric A. Adams"},"title":"President, Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-09-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-09-23","valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:document:67b5cdadce1a068f02322c3bf0fbc1dfa22a798b11fa670f243ee1e981ea7b54","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INM 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025090210/ea0253959-10k_inmed.htm","source_date":"2025-09-23T00:00:00+00:00","retrieved_at":"2026-05-16T03:59:45.35864+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-09-23T00:00:00+00:00","effective_from":"2025-09-23","effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:11","subject_id":"alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:netta-jagpal","object_label":"Netta Jagpal","object_source_name_forms":[],"value":"Netta Jagpal: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:netta-jagpal","name":"Netta Jagpal"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-09-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-09-23","valid_to":null,"recorded_at":"2026-10-21T04:47:21.26074+00:00","sources":[{"id":"alpha:projection-evidence:document:e0e90afaef68572d3c27f13be57966a41f4970916e9e6cacbc6af1018a380bc2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INM 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025090210/ea0253959-10k_inmed.htm","source_date":"2025-09-23T00:00:00+00:00","retrieved_at":"2026-05-16T03:59:45.819463+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-09-23T00:00:00+00:00","effective_from":"2025-09-23","effective_until":null,"observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"InMed Pharmaceuticals Inc. DEF 14A 2025-11-03","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm","source_date":"2025-11-03","retrieved_at":"2026-04-28T22:18:02.792+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:67b5cdadce1a068f02322c3bf0fbc1dfa22a798b11fa670f243ee1e981ea7b54","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INM 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025090210/ea0253959-10k_inmed.htm","source_date":"2025-09-23T00:00:00+00:00","retrieved_at":"2026-05-16T03:59:45.35864+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:e0e90afaef68572d3c27f13be57966a41f4970916e9e6cacbc6af1018a380bc2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"INM 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025090210/ea0253959-10k_inmed.htm","source_date":"2025-09-23T00:00:00+00:00","retrieved_at":"2026-05-16T03:59:45.819463+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.832,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.87,"cross_source_agreement":0.75,"temporal_completeness":0.538},"diagnostics":{"published_claims":20,"factual_claims":20,"claims_with_linked_evidence":20,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":13,"temporal_claims_with_valid_from":7,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-21T04:47:21.26074+00:00","observed_at":"2026-10-21T04:47:21.26074+00:00","reviewed_at":"2026-10-21T04:47:21.26074+00:00","verified_at":"2026-10-21T04:47:21.26074+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":20,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/inmed-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}